Technologies for
Transplantation Research

Explore emerging technologies from De Facto Diagnostics and our collaborators, designed to support scientific research and accelerate insight into transplantation-related questions.

Early Access
NovoSight cfDNA and Chimerism product boxes

NovoSight cfDNA

Sensitive Detection. Intelligent Scaling.

NovoSight cfDNA combines high-sensitivity donor-derived cfDNA analysis with a scalable NGS workflow and automated bioinformatics solution.

Designed to support accurate, precise quantification of donor-derived cfDNA, its flexible workflow accommodates varying sample volumes while automated data analysis minimizes hands-on review time.

Key Features

  • Accurate and precise quantification of donor-derived cfDNA
  • 100+ genomic markers maximize analytical confidence
  • Well-suited for multi-organ and/or re-transplant cases
  • Rapid turnaround from sample to report
  • Automated data analysis minimizes hands-on review time
  • Flexible workflow accommodates varying sample volumes
NovoSight Chimerism product box

NovoSight Chimerism

Highly Accurate. Highly Informative.

NovoSight Chimerism combines dense SNP interrogation, sophisticated computational analysis, and a simple NGS workflow to support laboratories of all sizes.

Automated analysis helps reduce interpretation time while informative genomic markers support donor/recipient quantification and mixed-chimerism detection.

Key Features

  • Highly accurate and precise donor/recipient quantification
  • Sensitive detection of mixed chimerism
  • 100+ genomic markers
  • Covers all chromosomes including X & Y
  • Dense coverage of Chr6p for HLA-LOH screening
  • Simple and scalable workflow
  • Automated analysis reduces interpretation time
Transplant Surveyor software display

Heirloom Diagnostics' Transplant Surveyor Software

Sophisticated Analytics. Operational Efficiency.

The Transplant Surveyor software platform combines advanced analytics with an intuitive interface to transform complex NGS data into clear results that simplify review and signoff.

A suite of powerful tools operates behind a thoughtfully designed interface to streamline laboratory efficiency and increase throughput.

Key Features

  • Proprietary analysis algorithms
  • Automated quality metrics
  • Supports challenging genetic relationships and complex transplant scenarios
  • Longitudinal tracking
  • Reduced manual interpretation
  • Simplified data review

* All De Facto Diagnostics, LLC products are Research Use Only (RUO) unless otherwise specified. NovoSight is a trademark of De Facto Diagnostics, LLC. Transplant Surveyor is a trademark of Heirloom Diagnostics, LLC.

Early Access Program

Interested in Evaluating Emerging Technologies?

Interested in evaluating the latest innovations in molecular surveillance in your laboratory?

Scan the QR code or contact us to get in the queue for our NovoSight Chimerism and NovoSight cfDNA Early Access Program.

The Early Access Program offers laboratories an opportunity to evaluate these technologies and helps De Facto Diagnostics and Heirloom Diagnostics collect critical information about product performance in different laboratory environments. Participation is limited.

Request Early Access
Early Access Program QR code